ISRCTN61320108已完成未知
A randomised controlled trial of the angiotensin II receptor blocker losartan (Cozaar®) in the prevention of hyperenzymemia after endoscopic retrograde cholangio-pancreaticography (ERCP)
Karolinska Institutet (Sweden)0 个研究点目标入组 80 人开始时间: 2010年1月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients above 18 years of age, either sex
- •2. ERCP indicated for diagnostic or therapeutic reasons
- •3. Informed consent
排除标准
- •1. Previous ERCP within one year
- •2. Current elevation of pancreatic amylase and lipase
- •3. Ongoing acute or chronic pancreatitis
- •4. Current use of any angiotensin I converting enzyme (ACE) inhibitor or angiotensin II type 1 receptor blocker
- •5. Bilateral renal artery stenosis or unilateral in case of a single kidney
- •6. Known hypersensitivity to angiotensin II type 1 receptor blockers
- •7. Pregnancy
- •8. Breastfeeding
- •9. Predefined severe disease (e.g. ongoing sepsis, disseminated intravascular coagulopathy, acute circulatory collapse, severe dehydration, hypovolaemia, severe renal insufficiency or severe liver failure)
研究者
相似试验
进行中（未招募）
1 期
A randomised controlled trial of the angiotensin converting enzyme inhibitor ramipril in asymptomatic aortic stenosis - Ramipril in aortic stenosis (RIAS)EUCTR2007-005224-32-GBniversity of Oxford100
已完成
不适用
A randomised controlled trial of the angiotensin converting enzyme (ACE) inhibitor ramipril in asymptomatic aortic stenosisISRCTN24616095niversity of Oxford (UK)100
尚未招募
不适用
Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertensioAtrial Fibrillation with hypertensionJPRN-UMIN000046613Cardiology University Northern Yokohama Hospital200
招募中
3 期
A randomized competitive trial of Angiotensin II Receptor Blocker (ARB) for prevention of tumor recurrence in non-muscle invasive bladder cancerBladder cancerJPRN-UMIN000005044Keio University Hospital200
已完成
不适用
A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with HypertensioAtrial Fibrillation with HypertensionJPRN-C000000427The J-RHYTHM II Investigators400